AAAAAA
Results:
1-16
|
Results: 16
Authors:
HERZER WA
THOMAS NJ
CARCILLO JA
TOFOVIC SP
JACKSON EK
Citation: Wa. Herzer et al., EFFECTS OF TYPE-IV PHOSPHODIESTERASE INHIBITION ON CARDIAC-FUNCTION IN THE PRESENCE AND ABSENCE OF CATECHOLAMINES, Journal of cardiovascular pharmacology, 32(5), 1998, pp. 769-776
Authors:
THOMAS NJ
HERZER WA
CARCILLO JA
JACKSON EK
Citation: Nj. Thomas et al., EFFECT OF THE TYPE-IV PHOSPHODIESTERASE INHIBITOR RO 20-1724 ON CATECHOLAMINE-INDUCED ALTERATIONS IN REGIONAL VASCULAR-RESISTANCE AND REGIONAL BLOOD-FLOW, Journal of cardiovascular pharmacology, 31(6), 1998, pp. 840-853
Authors:
KOST CK
HERZER WA
LI P
NOTOYA M
MIZUHIRA V
INAGAMI T
JACKSON EK
Citation: Ck. Kost et al., ANGIOTENSIN-II-INDUCED STRUCTURAL AND FUNCTIONAL ALTERATIONS IN SPONTANEOUSLY HYPERTENSIVE RAT-KIDNEY, American journal of physiology. Renal, fluid and electrolyte physiology, 39(1), 1996, pp. 229-236
Authors:
CARCILLO JA
HERZER WA
MI ZC
THOMAS NJ
JACKSON EK
Citation: Ja. Carcillo et al., TREATMENT WITH THE TYPE-IV PHOSPHODIESTERASE INHIBITOR RO-20-1724 PROTECTS RENAL AND MESENTERIC BLOOD-FLOW IN ENDOTOXEMIC RATS TREATED WITHNOREPINEPHRINE, The Journal of pharmacology and experimental therapeutics, 279(3), 1996, pp. 1197-1204
Authors:
JACKSON EK
MI ZC
KOEHLER MT
CARCILLO JA
HERZER WA
Citation: Ek. Jackson et al., INJURED ERYTHROCYTES RELEASE ADENOSINE-DEAMINASE INTO THE CIRCULATION, The Journal of pharmacology and experimental therapeutics, 279(3), 1996, pp. 1250-1260
Authors:
BEGANY DP
CARCILLO JA
HERZER WA
MI ZC
JACKSON EK
Citation: Dp. Begany et al., INHIBITION OF TYPE-IV PHOSPHODIESTERASE BY RO-20-1724 ATTENUATES ENDOTOXIN-INDUCED ACUTE-RENAL-FAILURE, The Journal of pharmacology and experimental therapeutics, 278(1), 1996, pp. 37-41
Authors:
KOST CK
HERZER WA
LI P
NOTOYA M
MIZUHIRA V
INAGAMI T
JACKSON EK
Citation: Ck. Kost et al., RENAL STRUCTURAL AND FUNCTIONAL ALTERATIONS DURING PROLONGED ANGIOTENSIN-II (ANGII) INFUSION IN THE SPONTANEOUSLY HYPERTENSIVE RAT, The FASEB journal, 9(3), 1995, pp. 53-53
Authors:
BEGANY DP
HERZER WA
MI ZC
CARCILLO JA
JACKSON EK
Citation: Dp. Begany et al., RENAL TISSUE ADENOSINE IS ELEVATED IN THE ENDOTOXIN-TREATED RAT, Pediatric research, 37(4), 1995, pp. 42-42
Authors:
JACKSON EK
HERZER WA
Citation: Ek. Jackson et Wa. Herzer, DEFECTIVE MODULATION OF ANGIOTENSIN-II-INDUCED RENAL VASOCONSTRICTIONIN HYPERTENSIVE RATS, Hypertension, 23(3), 1994, pp. 329-336
Authors:
MI ZC
HERZER WA
ZHANG Y
JACKSON EK
Citation: Zc. Mi et al., 3-ISOBUTYL-1-METHYLXANTHINE DECREASES RENAL CORTICAL INTERSTITIAL LEVELS OF ADENOSINE AND INOSINE, Life sciences, 54(16), 1994, pp. 277-282
Authors:
JACKSON EK
HERZER WA
KUAN CJ
Citation: Ek. Jackson et al., ROLE OF ADENOSINE IN NORADRENERGIC NEUROTRANSMISSION DURING HEMORRHAGIC HYPOTENSION, The Journal of pharmacology and experimental therapeutics, 270(2), 1994, pp. 589-594
Authors:
KOST CK
HERZER WA
LI P
JACKSON EK
Citation: Ck. Kost et al., VASCULAR REACTIVITY TO ANGIOTENSIN-II IS SELECTIVELY ENHANCED IN THE KIDNEYS OF SPONTANEOUSLY HYPERTENSIVE RATS, The Journal of pharmacology and experimental therapeutics, 269(1), 1994, pp. 82-88
Authors:
JACKSON EK
HERZER WA
Citation: Ek. Jackson et Wa. Herzer, ANGIOTENSIN-II PROSTAGLANDIN-I(2) INTERACTIONS IN SPONTANEOUSLY HYPERTENSIVE RATS/, Hypertension, 22(5), 1993, pp. 688-698
Authors:
KUAN CJ
HERZER WA
JACKSON EK
Citation: Cj. Kuan et al., CARDIOVASCULAR AND RENAL EFFECTS OF BLOCKING-A(1) ADENOSINE RECEPTORS, Journal of cardiovascular pharmacology, 21(5), 1993, pp. 822-828
Authors:
JACKSON EK
HERZER WA
SUZUKI F
Citation: Ek. Jackson et al., KF17837 IS AN A(2) ADENOSINE RECEPTOR ANTAGONIST IN-VIVO, The Journal of pharmacology and experimental therapeutics, 267(3), 1993, pp. 1304-1310
Authors:
JACKSON EK
HERZER WA
Citation: Ek. Jackson et Wa. Herzer, DEFECTIVE MODULATION OF ANGIOTENSIN-II-INDUCED VASOCONSTRICTION BY PROSTAGLANDIN-I2 IN THE KIDNEY, BUT NOT MESENTERY, OF SPONTANEOUSLY HYPERTENSIVE RATS, Circulation, 88(4), 1993, pp. 454-454
Risultati:
1-16
|